Editorial
 NATIONAL IPR POLICY   
 Thursday, September 03, 2015 
 Implementation of India’s amended Patent Act allowing grant of product patent in pharmaceutical industry has been facing major hurdles ever since 2005 with the long drawn litigations in the patent offices and various courts in the country. 
  Past Editorial...  
TODAY'S NEWS
17:00  [IST]Amgen seeks EU marketing approval for etelcalcetide to treat SHPT in patients with CKD on hemodialysis therapy
16:00  [IST]Allergan gets US FDA nod for updated label for Teflaro to treat patient with ABSSSI & CABP
15:35  [IST]Lupin launches first ever variant of anti-depressent drug, duloxetine in US
15:05  [IST]Apollo Hospitals Chennai leads the way in high risk pregnancy
15:00  [IST]Lannett to buy UCB's specialty generic pharma unit, Kremers Urban Pharma for $1.23 bn
14:30  [IST]US FDA approves Janssen Biotech's updated label for Simponi Aria
more news >>
TOP NEWS
08:00  [IST]ICMR issues draft consensus document for management of paediatric lymphomas and solid tumours
08:00  [IST]OPD non functional at SCRI in Chennai even after ministry of Ayush was formed
08:00  [IST]IMA Maharashtra objects to order to prescribe generic drugs as most chemists hardly available in state
08:00  [IST]TSMI Karnataka to hold conclave on Impact & Trends in Telemedicine on Sept 12 at Whitefield
08:00  [IST]Telangana State sends proposal to MCI for setting up 3 medical colleges in state
08:00  [IST]D&C Rules to be amended to make only registered pharmacists eligible to become wholesalers
more news >>
YESTERDAY'S NEWS
18:00  [IST]Alexion receives European marketing approval for Strensiq to treat patients with HPP
17:10  [IST]Glenmark’s GBR 830 to enter phase 2 studies in AD and celiac disease in US & Europe
17:00  [IST]Mobidiag, Unilabs ink pact to use Amplidiag product line for molecular gastrointestinal diagnostics
16:30  [IST]SGI-DNA introduces Gibson Assembly site-directed mutagenesis kit
16:00  [IST]Probiodrug licenses TBA 2.1 transgenic Alzheimer’s disease mouse model to QPS Austria Neuropharmacology
15:30  [IST]Pharmalytica pitches on optimising potentials of current pharma landscape
more news >>
INTERVIEW  
IDMA taking steps to strengthen and tap biz opportunities for SMEs
S.V. Veerramani, the new president of the Indian Drugs Manufacturers Association (IDMA)
Past Interviews...
 
  What's New?  
 
Opinion Poll
 
 
Should the Pharmacy Inspectors be stopped from inspecting pharmacy outlets as is being demanded by All Kerala Chemists and Druggists Association ?
 
 
 
 

   
 
 
  Corporate
Pharma Stocks
Executive Diary
Pharma People
Product Launches
  Special Features
Features
  Chronicle Pharmabiz Specials
Forthcoming
  Past
 
  Forthcoming Events
International
  Domestic
 
TENDERS & PROJECTS
Tenders & Enquiries
Pharma Projects
CORPORATE
Company Profile
Corporate Results
Corporate X-ray
Pharmabiz Studies of Top Companies
US FDA UPDATE
US FDA: ANDA
US FDA: Warnings
US FDA: Approved NMEs
US FDA: New Approvals
US FDA: REFUSAL
EXPORT & IMPORT
Drug Export Procedures
Drug Units With WHO GMP Certification
Pharma Export Data
Import Reg. Update
PHARMA LAWS & DOCUMENTS
Notifications
Pharma Regulations
Patent Laws and Amendments
Patent Scan
Documents
New Drug Approvals
Notified Prices
LIST OF LABS & GOVT. BODIES
Govt Recognised In-House R&D Units
AICTE Boards & Committees
List of Indian CROs
List of CROs (International)
Govt & approved labs of India
List of State Drugs Controllers
 
 
 
 
 
 
Copyright © 2015 Saffron Media Pvt. Ltd |